GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (STU:NNFN) » Definitions » Short Percentage of Float

MannKind (STU:NNFN) Short Percentage of Float


View and export this data going back to . Start your Free Trial

What is MannKind Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of MannKind's Short Percentage of Float

For the Biotechnology subindustry, MannKind's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MannKind's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MannKind's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where MannKind's Short Percentage of Float falls into.


MannKind Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (STU:NNFN) » Definitions » Short Percentage of Float
Comparable Companies
AGIO IRON NMRA SLNO HRMY WVE AKRO MIRM FTRE GERN VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
MNKD:USA NNFN:Germany
Address
1 Casper Street, Danbury, CT, USA, 06810
Website
https://www.mannkindcorp.com
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind Headlines

No Headlines